大麻股票
165.09k 個跟隨者 • 20 個股票代號 追蹤清單由 Yahoo Finance 提供
跟隨此名單即可探索和追蹤大麻相關之上市公司的股票
策劃人： Yahoo Finance
根據大麻市場研究公司 Arcview Market Research and BDS Analytics 聯合發表的報告顯示，全球合法大麻支出在未來十年將達到 570 億美元。由於休閒和醫療大麻合法化，加上公眾對這兩種大麻的需求不斷增加，到了 2022 年美國合法大麻收入預計將達到 234 億美元。雅虎財經目前正在追蹤大麻行業的主要競爭者。
我們如何選股？這張精選名單由雅虎財經的演算法、我們數百萬用戶的情報以及雅虎財經編輯團隊的資料整理而成。此名單涵蓋園藝、製藥研究和輔助業務的公司。隨著越來越多公司投資並進入這個行業，我們會持續新增名單。
這些股票如何加權？此觀察名單中的股票已在加入時給予相同權重。
如需了解此名單中每間公司所從事的大麻相關業務，請閱讀此報導。
表現
| 追蹤清單 | 今日股價變化 | 1 個月回報 | 1 年回報 | 總回報 |
|---|---|---|---|---|
| 大麻股票 | +0.25% | +58.10% | -9.72% | +327.19% |
| ^GSPC | -0.22% | -3.23% | +20.62% | +5288.30% |
20 個股票代號
| 代號 | 公司名稱 | 收市價 | 變化 | % 變化 | 市場時間 | 成交量 | 平均成交量 (3 個月) | 市值 |
|---|---|---|---|---|---|---|---|---|
| ABBV | AbbVie Inc. | 164.66 | +0.41 | +0.25% | 下午4:00 [EDT] | 4.48M | 5.64M | 291.56B |
| BUD | Anheuser-Busch InBev SA/NV | 57.91 | +0.55 | +0.96% | 下午4:00 [EDT] | 1.45M | 2.22M | 114.14B |
| MO | Altria Group, Inc. | 41.3 | +0.20 | +0.49% | 下午4:01 [EDT] | 14.72M | 12.35M | 70.94B |
| TAP | Molson Coors Beverage Company | 63.88 | +0.34 | +0.54% | 下午4:00 [EDT] | 1.48M | 1.74M | 13.56B |
| SMG | The Scotts Miracle-Gro Company | 67.96 | +0.26 | +0.38% | 下午4:00 [EDT] | 370.72k | 787.99k | 3.85B |
| TLRY | Tilray Brands, Inc. | 1.72 | - | - | 下午4:00 [EDT] | 30.15M | 29.29M | 1.33B |
| WEED.TO | Canopy Growth Corporation | 10.79 | +1.88 | +21.10% | 下午4:00 [EDT] | 4.60M | 2.90M | 983.13M |
| CRON | Cronos Group Inc. | 2.41 | -0.01 | -0.41% | 下午4:00 [EDT] | 3.93M | 2.95M | 918.93M |
| CGC | Canopy Growth Corporation | 7.83 | +1.34 | +20.65% | 下午4:00 [EDT] | 16.37M | 11.25M | 715.64M |
| CRBP | Corbus Pharmaceuticals Holdings, Inc. | 36.53 | -0.63 | -1.70% | 下午4:00 [EDT] | 127.79k | 980.07k | 383.83M |
| ACB | Aurora Cannabis Inc. | 6.535 | +0.74 | +12.87% | 下午4:00 [EDT] | 8.71M | 5.60M | 357.06M |
| CANN | Trees Corporation | 0.0801 | +0.00 | +0.25% | 下午3:41 [EDT] | 95.14k | 81.12k | 8.71M |
| GWPH | - | - | - | - | - | - | - | - |
| MJ | Amplify Alternative Harvest ETF | 3.8 | +0.04 | +1.06% | 下午4:00 [EDT] | 2.62M | 3.20M | - |
| NBEV | - | 0.0935 | -0.03 | -25.20% | 下午4:00 [EDT] | 46.01M | - | - |
| TGOD.TO | - | - | - | - | - | - | - | - |
| TRST.TO | - | - | - | - | - | - | - | - |
The Wall Street JournalAmerica’s Cigarette Market Is Up for Grabs
Philip Morris will soon be able to sell its most successful smoke-free product in the U.S., setting up a battle with its former parent company Altria.
PR NewswireCanopy Growth Announces CBI Conversion to Exchangeable Shares and Newly Constituted Board of Directors
Canopy Growth Corporation ("Canopy Growth" or the "Company") (TSX: WEED) (NASDAQ: CGC) announced today that in connection with the creation of the non-voting and non-participating exchangeable shares in the capital of Canopy Growth (the "Exchangeable Shares"), on April 18, 2024, Greenstar Canada Investment Limited Partnership ("Greenstar") and CBG Holdings LLC ("CBG" and, together with Greenstar, the "CBG Group"), each a wholly-owned subsidiary of Constellation Brands, Inc. ("CBI"), exchanged al
BenzingaSoon To Be Acquired Cerevel Therapeutics Reveals High Level Data From Late-Stage Parkinson's Disease Study
On Thursday, Cerevel Therapeutics Holdings Inc. (NASDAQ:CERE) released topline results from its pivotal Phase 3 TEMPO-3 trial for tavapadon in Parkinson’s disease. The TEMPO-3 trial evaluated the efficacy, safety, and tolerability of tavapadon as an adjunctive therapy to levodopa (LD) in adults. The trial met its primary endpoint – patients treated with tavapadon adjunctive to LD experienced a clinically meaningful and statistically significant increase of 1.1 hours in total “on” time without tr
